Fibrocell Science, Inc.·4

Jan 25, 4:56 PM ET

Korkos George J 4

4 · Fibrocell Science, Inc. · Filed Jan 25, 2011

Insider Transaction Report

Form 4
Period: 2011-01-21
Transactions
  • Award

    Series D convertible preferred stock

    2011-01-21+25450,000 total
    Exercise: $0.50From: 2011-01-21Common Stock (50,000 underlying)
  • Award

    Warrant (right to buy)

    2011-01-21+50,000500,000 total
    Exercise: $0.50From: 2011-01-21Exp: 2016-01-21Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Each share of Series D convertible preferred stock has a stated value of $1,000 and is convertible into shares of common stock at a rate of $0.50 per share (or 2,000 shares of common stock for each share of Series D convertible preferred stock). The Series D convertible preferred stock has no expiration date.
  • [F2]The Series D convertible preferred stock and warrants were issued in units, each unit with a purchase price of $1,000 per unit and consisting of one share of Series D convertible preferred stock and warrants to purchase 2,000 shares of common stock. The reporting person acquired 25 units.

Documents

1 file
  • 4
    c11408_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION